Application Nr Approved Date Route Status External Links
ANDA091261 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Levetiracetam Extended-Release Tablets Are Indicated As Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Patients 12 Years Of Age And Older With Epilepsy. Levetiracetam Extended-Release Tablets Are Indicated For Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Patients 12 Years Of Age And Older With Epilepsy ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levetiracetam LEVETIRACETAM ZINC1547851

Comments